openPR Logo
Press release

Enhanced Deubiquitination Assay Service Now Available from Creative BioMart

12-22-2025 10:55 AM CET | Health & Medicine

Press release from: Creative Biomart

Creative BioMart is pleased to announce the upgrade of its protein deubiquitination assay service, providing researchers with a more sensitive, flexible, and high-throughput platform to study deubiquitinating enzymes (DUBs). This service supports both fundamental research and drug discovery in ubiquitin biology, enabling precise quantification and characterization of enzyme activity.

Deubiquitination - the removal of ubiquitin from substrate proteins by DUBs - is a critical cellular process, regulating protein stability, signal transduction, DNA repair, and many other essential pathways. Accurate measurement of DUB activity is vital for understanding these processes and for identifying potential therapeutic targets.

The upgraded assay employs a fluorescent ubiquitin-based substrate, allowing detection of DUB activity in purified recombinant proteins or cell extracts from human, mouse, or rat samples. Fluorescence readouts (excitation/emission ~485/535 nm) provide reliable kinetic and endpoint measurements, making the platform suitable for enzyme profiling, comparative activity studies, and inhibitor screening.

Creative BioMart complements this assay with a full suite of protein services, including protein expression and purification (bacterial, insect, mammalian), custom labeling (fluorescent, biotin, His, Fc), protein interaction analysis, post-translational modification profiling (ubiquitination, phosphorylation, acetylation, SUMOylation), and high-throughput screening. These offerings allow researchers to design integrated workflows tailored to their specific experimental goals.

Linna, Chief Marketing Officer at Creative BioMart, remarked:

"Our enhanced deubiquitination assay offers a robust and flexible solution for exploring DUB function and accelerating drug discovery. With the holiday season approaching, we are also offering special promotions on our services and products, giving researchers the opportunity to access high-quality assays at discounted rates."

As part of Creative BioMart's 2025 Christmas Special Promotion, clients can enjoy 15% off custom services and 20% off research products, valid from December 8, 2025 to January 11, 2026. Researchers can apply the coupon code CBMXMAS25 in their project inquiry to take advantage of this offer.

For more information about the upgraded protein deubiquitination assay and the holiday promotion, please visit https://www.creativebiomart.net/protein-deubiquitination-assay.htm.

Ramsey Road, Shirley, NY 11967, USA

Creative BioMart began as a supplier focused on the development and production of recombinant protein products. Over the years, we have grown exponentially to offer over 100,000 protein products, including native proteins, cell/tissue lysates, chromatography, lectins, and detection kits.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enhanced Deubiquitination Assay Service Now Available from Creative BioMart here

News-ID: 4323413 • Views:

More Releases from Creative Biomart

Creative BioMart Launches Enhanced Protein Phylogenetic Analysis Service to Deepen Evolutionary Insight
Creative BioMart Launches Enhanced Protein Phylogenetic Analysis Service to Deep …
Creative BioMart, a biotechnology company known for integrating bioinformatics and protein research, today announced a major update to its protein phylogenetic analysis service. The upgraded service is intended to provide clients with more flexible, accurate, and interpretable evolutionary analyses of protein families, supporting both academic research and industry R&D. Protein phylogenetic analysis is the investigation of evolutionary relationships among proteins, helping researchers trace gene family origins, infer functional divergence, and identify
Creative BioMart Enhances Epitope Mapping Services to Support Antibody and Vacci …
Creative BioMart, a biotechnology company focused on protein-related research solutions, has recently upgraded its epitope mapping service to better support researchers in therapeutic antibody development, vaccine design, and immunogenicity studies. The updated platform integrates multiple experimental approaches with customizable strategies, enabling more accurate identification of antibody binding sites and antigenic determinants. Epitope mapping is a fundamental tool in immunology and molecular biology, used to pinpoint the characterizing monoclonal antibodies, guiding vaccine
Creative BioMart Launched an Integrated Neuroscience Technology Platform
Creative BioMart Optogenetics, a sub-brand of Creative BioMart that focused in the field related to genetics and biological product production, recently established an integrated neuroscience technology platform that incorporated cell culture, model biology R&D, and optogenetic equipment. Optogenetics is a field of science that uses light to control gene-driven neural activity. The accuracy of time and space is one of its advantages. Optogenetic experiments only control the activation or inhibition of
Creative BioMart Microbe Provides Microbiotherapy Research Technical Service Wor …
Creative BioMart Microbe, a sub-brand of Creative BioMart, provides high quality and high efficiency microbiological services and products to multi-industry customers, now provides medical microbiology researchers with multiple technical services related to microbiotherapy research to help customers advance their research. Microorganisms play a key role in human health and the occurrence and development of some diseases. The use of microorganisms as a therapeutic method has been one of the research hotspots

All 5 Releases


More Releases for DUB

SUI Crypto Holders Back Remittix After Experts Dub It The Number One Crypto To B …
SUI crypto has been on a tear lately. It has broken out of a bullish pattern and is aiming for resistance at $3.1. But even as SUI's native ecosystem shows promise, cracks are appearing: recent hacks, forced liquidations, and sell pressure have reminded holders that momentum can reverse fast. Many SUI investors are now hedging by rotating capital into projects with cross-chain, payment-led narratives. A growing fraction of SUI holders are
DUB Inhibitors Pipeline 2025: Comprehensive Clinical Trials and Therapies Analys …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, DUB Inhibitors pipeline constitutes key companies continuously working towards developing DUB Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "DUB Inhibitors Pipeline Insight" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the DUB Inhibitors Market. The DUB Inhibitors Pipeline report
DUB Inhibitors Pipeline 2025: Comprehensive Clinical Trials and Therapies Analys …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, DUB Inhibitors pipeline constitutes key companies continuously working towards developing DUB Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "DUB Inhibitors Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/dub-inhibitors-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the DUB Inhibitors Market. The DUB Inhibitors Pipeline report embraces in-depth
Dysfunctional Uterine Bleeding Market Overview: Global Size, Share, Analysis, an …
" The Dysfunctional Uterine Bleeding (DUB) market is a significant and growing sector within the healthcare industry, driven by the increasing prevalence of abnormal uterine bleeding among women globally. DUB, characterized by irregular or heavy menstrual bleeding not associated with structural abnormalities of the uterus or systemic disease, affects a substantial portion of the female population, impacting their quality of life and healthcare utilization. Key drivers for growth in this market
DUB Inhibitors Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, DUB Inhibitors pipeline constitutes key companies continuously working towards developing DUB Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "DUB Inhibitors Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the DUB Inhibitors Market. The DUB Inhibitors Pipeline report offers a comprehensive
DUB Inhibitors Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, DUB Inhibitors pipeline constitutes key companies continuously working towards developing DUB Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "DUB Inhibitors Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the DUB Inhibitors Market. The DUB Inhibitors Pipeline